In January 2025, the Company entered into an amendment agreement with AMF Medical that removed contingent liabilities included in the original share purchase agreement entered into in 2022.
channels so our customers’ orders can be serviced. While we have been working to increase our sales in the United States through our direct third-party payor contracts, the percentage is currently le…
in-process research and development assets with no alternative future use, and acquisition related expenses, on its consolidated statements of operations in acquired in-process research and developme…
channels so our customers’ orders can be serviced. While we have been working to increase our sales in the United States through our direct third-party payor contracts, the percentage is currently le…
Tandem Diabetes Care, Inc. Debt Obligations
Instrument
Description
Confidence
Evidence
TNDM-DEBT-13036
Xbrl Convertible
90%
xbrl convertible detail from xbrl 2025-12-31.
TNDM-DEBT-13035
Warrants outstanding: 73.73
90%
xbrl warrant detail from xbrl 2024-12-31.
TNDM-DEBT
Debt stack $734.7M
90%
Market cache reports total debt of $734.7M.
Tandem Diabetes Care, Inc. Acquisitions
No acquisitions on recordNo completed or pending acquisitions found in our database for Tandem Diabetes Care, Inc..
Tandem Diabetes Care, Inc. Ownership
Holder
Name
Confidence
Evidence
TNDM-OWNER-BLACKROCK-INC
BlackRock, Inc.
90%
13F overlay lists BlackRock, Inc. as top holder; 277 tracked holders.
Tandem Diabetes Care, Inc. Extended Supply Chain Network
